TrialClinical and experimental nephrology2006

Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure.

David Saltissi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.